Can a lower steroid dose preserve strength in young boys with DMD?

NCT ID NCT05412394

First seen Aug 14, 2026 ยท Last updated Aug 14, 2026

Summary

This trial is testing whether a lower weekly dose of the corticosteroid prednisolone (5 mg/kg per week) can be as effective as the standard higher dose (10 mg/kg per week) in preserving motor function in young boys with Duchenne muscular dystrophy (DMD). The study will enroll boys aged 1 to 30 months who have a confirmed DMD diagnosis and have not yet been treated with glucocorticosteroids. Over 24 months, researchers will measure changes in gross motor skills, as well as language, social, and fine motor development, to see if the lower dose offers a better balance of benefit and side effects.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
prednisolone (a corticosteroid)
What this could lead to
If effective, a lower weekly dose of prednisolone could offer a safer, equally effective treatment option for young boys with Duchenne muscular dystrophy, potentially reducing side effects.
What could go wrong
This is a small, early-phase trial, and the lower dose may not be as effective as the standard dose. Corticosteroids can have significant side effects, especially in young children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lurie Children's Hospital of Chicago

    RECRUITING

    Chicago, Illinois, 60611, United States

  • Nationwide Children's Hospital

    RECRUITING

    Columbus, Ohio, 43205, United States

  • University of Cincinnati

    RECRUITING

    Cincinnati, Ohio, 45220, United States

  • University of Texas Southwestern

    RECRUITING

    Dallas, Texas, 75235, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.